A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs
Crossref DOI link: https://doi.org/10.1007/s11306-014-0733-z
Published Online: 2014-09-19
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O′Hagan, Steve
Swainston, Neil
Handl, Julia
Kell, Douglas B.
License valid from 2014-09-19